The BIOMIC is a computerized system used to calculate the minimal inhibitory concentration (MIC) of an antimicrobial agent from a zone of inhibition generated by a disk diffusion test. This system was developed using bacterial pathogens of human origin. This study investigated the use of the BIOMIC system for determining MICs for bacterial pathogens from animals. The MICs generated by the BIOMIC system were compared with the MICs generated using a broth microdilution testing method. A total of 663 drug-organism combinations was tested. These combinations included 3 species of gram-positive bacteria, 5 species of gramnegative bacteria, and the antimicrobial agents ampicillin, gentamicin, cephalothin, ciprofloxacin, enrofloxacin, trimethoprim/sulfamethoxazole, tetracycline, and erythromycin. Overall, the MICs generated by the BIOMIC system correlated with the broth microdilution MICs for 72% of the total drug-organism combinations tested. The Pseudomonas aeruginosa strains tested showed the highest agreement between the 2 systems, with 100% for all antibacterial agents tested, whereas Pasteurella haemolytica, Pasteurella multocida, and enterococci showed the least agreement (76%, 57%, and 47%, respectively). Among these organisms, trimethoprim-sulfa showed the least agreement (31%) and ciprofloxacin showed the greatest (91%). These results indicate that the BIOMIC system could be a useful tool in veterinary medicine for producing quantitative antimicrobial susceptibility results. However, it is currently unreliable for some drug-bacteria combinations. This discrepancy possibly could be corrected by modification of the software using data points generated by a large-scale study.
The importance of antibacterial chemotherapeutic agents in the treatment of infectious disease processes is well established. Historically, a practitioner could select an effective drug based on clinical experience. However, with an increase in bacterial resistance to commonly used antibacterial agents, it has become increasingly difficult for clinicians to empirically select an appropriate antibacterial agent. An alternative to empirically selecting an antibacterial agent is in vitro antimicrobial susceptibility testing on bacteria isolated from properly collected samples. There are basically 2 types of results that are provided by in vitro susceptibility testing: qualitative results, i.e., susceptible, intermediate, or resistant, and quantitative results, i.e., the minimum concentration of an antimicrobial agent required to inhibit the growth of the bacteria (MIC).
Two common in vitro methods for determining susceptibility profiles of bacterial pathogens are disk diffusion testing and dilution testing. Disk diffusion testing involves applying a single concentration of an antimicrobial agent to a seeded agar medium and allowing the drug to diffuse into the surrounding medium. The bacteria on the agar medium are thus exposed to a continuous gradient of drug with the concentration diminishing as the distance from the disk increases. A zone of inhibition forms when the concentration of drug reaches a concentration of bacteria it can no longer inhibit. The edge of this zone thus represents an MIC. However, because the concentration of the antibacterial agent at the edge of the zone of inhibition may vary for each drug-bacterium combination, the MIC cannot be easily determined. Thus, the results generated by the disk diffusion are qualitative in contrast with dilution testing, in which the MIC is generated providing quantitative results. The advantages of the disk diffusion method are the low cost and the ease in modifying test formats when needed. However, because the susceptible category generated by the disk diffusion test shows reasonable but incomplete correlation with clinical outcome, there is a need for more precise interpretation of results from in vitro antibacterial susceptibility testing. 2 Studies comparing clinical response with in vitro data generated from dilution testing have shown that treatment failures are more frequently associated with higher MICs. 2, 4 Although there are several methods for performing dilution antimicrobial susceptibility tests, the method most commonly used in veterinary diagnostic bacteriology laboratories is the broth microdilution test. Because most broth microdilution test panels used in veterinary medicine are prepared commercially, they are less flexible in adjusting to the changing needs of the practitioner and are more expensive to use than the disk diffusion method. However, the results generated from dilution testing allow the practitioner to alter the dose or frequency of administration based on the MIC of the pathogen. The BIOMIC a system was developed so that quantitative results could be generated from a testing method that had the flexibility and cost effectiveness of the disk diffusion test.
The BIOMIC system provides both qualitative and quantitative information through the derivation of the MIC from the zone diameter measurement based on their inverse linear relationship. In other words, a large zone of inhibition will, in theory, correspond with a small MIC, and a small zone will correspond to a large MIC. This system is both reliable and cost effective when compared with traditional dilution testing on human bacterial pathogens. 1, 3, 10 However, its merits for use with animal pathogens have not been examined.
In the present study, the MICs generated by the BIOMIC system were compared with those generated by the broth microdilution test for routinely used antimicrobial agents tested against common bacterial pathogens of importance in veterinary medicine. 7
Materials and methods
Organisms. One hundred thirty-one veterinary clinical bacterial isolates were used for this study: Staphylococcus aureus (10 isolates), Staphylococcus intermedius (10), Enterococcus spp. (27), Pseudomonas aeruginosa (10), Pasteurella haemolytica (29), Pasteurella multocida (26), Escherichia coli (9) , and Klebsiella pneumoniae (10) . The reference strains used for quality control were S. aureus ATCC 29213 (microdilution tests), S. aureus ATCC 25923 (disk diffusion tests), and E. coli ATCC 25922. 7 Once isolated and identified, the clinical isolates were stored in sterile defibrinated sheep blood at Ϫ70 C. The day before testing, the organisms were thawed and streaked for isolation on a Columbia agar-based medium b supplemented with 5% defibrinated sheep blood, c 1% yeast extract, d and 1% horse serum e (EBA). The agar plates were incubated for 20-24 hr at 35-37 C in an atmosphere of 5% CO 2 .
Disk diffusion tests. Colonies of the test organisms that grew overnight were taken directly from the EBA plates and suspended in sterile water to an optical density equivalent to a 0.5 McFarland standard. Disk diffusion testing was performed according to the NCCLS M2-A6 document. 8 Mueller-Hinton (MH) agar b was used as the test medium for all organisms except P. haemolytica, which was tested on MH agar supplemented with 5% defibrinated sheep blood. The inoculated plates were stacked no more than 2 high and incubated for 20-24 hr at 35-37 C in ambient air. Zones of inhibition were read using an electronic caliper connected to a computer preprogrammed with the BIOMIC program. The BIOMIC system then calculated MICs from the agar diffusion gradient using regression line analysis. 3 Broth microdilution tests. Colonies of the test organisms that grew overnight were taken from the EBA plates and suspended in sterile water to an optical density equivalent to a 0.5 McFarland standard. Dilution tests were performed in accordance with the procedures outlined in the NCCLS M7-A4 document. 6 Broth microdilution trays were prepared in the laboratory. All antimicrobial agents were prepared in accordance with the manufacturer's instructions or, when not available, with the NCCLS M7-A4 document guidelines. 6 Broth microdilution trays were stacked no more than 2 high and incubated for 20-24 hr at 35-37 C in ambient air.
Interpretation of results. To compare MICs generated by the BIOMIC system with MICs generated by the broth microdilution method, the BIOMIC MIC was divided by the broth microdilution MIC (BIOMIC/MIC). The BIOMIC MICs were considered to be in agreement with the broth microdilution MICs when the ratios were between 0.5 and 2.0. 3 The BIOMIC MICs were considered not in agreement with the broth MICs when the ratios were Յ0.25 or Ն4.0. Because the MICs generated by the BIOMIC system were calculated to the nearest 0.1 g/ml, the ratios did not always match the doubling dilutions generated by the broth microdilution method. Thus, when the ratios fell between 0.25 and 0.5 they were expressed as 0.5, when they were between 0.5 and 1.9 the ratios were expressed as 1 and ratios between 2.0 and 3.9 were recorded as 2. If the MIC generated by both test methods was read either as ''less than'' or ''greater than,'' the ratio was considered to be 1. The ratio was also considered to be 1 if the BIOMIC MIC was ''less than'' and the broth microdilution MIC was ''less than or equal to'' or if the BIOMIC MIC was ''greater than'' and the broth microdilution MIC was ''greater than or equal to.''
Results
Initially, the MIC agreement between the BIOMIC and the broth microdilution method involved 231 bacteria-antibacterial agent combinations. There was an 88% correlation between the 2 systems for the grampositive bacteria and an 85% correlation for the gramnegative bacteria ( Table 1 ). The major discrepancy for the gram-positive bacteria was due to the Enterococcus spp., which showed only a 30% agreement in MICs between the 2 methods when testing gentamicin ( Table  2) . Although the overall agreement for the gram-negative bacteria was Ͼ80%, there were major discrepancies with P. haemolytica and P. multocida. There was a 59% agreement between the 2 methods for P. haemolytica and a 78% agreement for P. multocida. When the results for individual bacteria-drug combinations were examined, P. multocida showed Ͻ70% agreement for ampicillin and P. haemolytica showed Ͻ70% agreement for all 3 of the drugs tested. Because of these results, an additional 17-20 isolates of P. multocida, P. haemolytica, and Enterococcus spp. were tested against ampicillin, cephalothin, and gentamicin plus 5 additional antibacterial agents: ciprofloxacin, trimethoprim/sulfamethoxazole, erythromycin, enrofloxacin, and tetracycline.
The additional testing resulted in 432 bacteria-drug combinations ( Table 3 ). Agreement between the BIOMIC MICs and the MICs obtained from the broth microdilution method was 64%. The BIOMIC MICs for the Enterococcus spp. were lower than the broth microdilution MICs for ampicillin, ciprofloxacin, gentamicin, erythromycin, and enrofloxacin. Pasteurella multocida had lower BIOMIC MICs for cephalothin and gentamicin. However, all 3 organisms had BIOM-IC MICs that were greater than the MICs obtained from broth microdilution testing for trimethoprim/sulfamethoxazole, erythromycin, and tetracycline. Overall, there was a 76% agreement for the P. haemolytica isolates for bacteria-drug combinations, 65% agreement for the P. multocida isolates, and 49% agreement for the Enterococcus spp. Cephalothin had an overall agreement (0.5-2) of 100% with Enterococcus spp. and P. haemolytica. Ciprofloxacin and enrofloxacin both had an overall agreement of 100% with P. multocida. However, only the P. haemolytica-ciprofloxacin combination resulted in a BIOMIC/MIC ratio of 1.
Discussion
The BIOMIC system is a reliable method for obtaining quantitative in vitro antimicrobial susceptibility results from the disk diffusion testing procedure when testing human bacterial pathogens. 1, 3, 10 However, some identification systems use databases that were generated using bacteria isolated from humans and thus are unreliable for identifying bacteria isolated from ani- The trend with Enterococcus spp. was toward lower BIOMIC MICs and therefore lower BIOMIC/MIC ratios. This trend could be attributed to a slow growth rate of Enterococcus on the MH agar medium. A slow growth rate would result in larger zones of inhibition, which would be interpreted by the BIOMIC as smaller MICs. Pasteurella haemolytica, however, demonstrated a trend towards higher BIOMIC MICs, possibly because of increased growth rate on the agar medium or decreased growth rate in the broth microdilution tray. If there were a reduced growth rate in the microdilution tray, it could have been due to incubating the trays aerobically rather than under CO 2 . Overall there was no predictable trend for P. multocida. Instead, the MIC seemed to be based more on the antibacterial agent being tested than the method tested. For example, against ampicillin, P. multocida tended to have lower BIOMIC MICs, whereas when tested against erythromycin the BIOMIC MICs were greater than those generated by the broth microdilution method.
The discrepancies between the BIOMIC MICs and the MICs generated by the broth microdilution method might be explained by the BIOMIC system's limited testing with veterinary isolates. Although Pasteurella spp. have been known to cause disease in humans, their involvement in infectious diseases remains primarily in veterinary medicine. The Pasteurella spp., therefore, may not have been adequately represented in the BIOMIC database. As seen previously, commercial systems that are useful for testing human pathogens need additional modifications to accurately test veterinary pathogens. 5, 8 The data presented here suggest that the BIOMIC system is potentially useful to the veterinary community for obtaining quantitative results from in vitro antimicrobial susceptibility testing, but its database would have to be expanded to include veterinary pathogens. A larger study testing a wide variety of veterinary pathogens and antimicrobial agents would have to be performed to confirm the extent of the modifications needed by the BIOMIC system to service veterinary diagnostic laboratories.
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